SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-014889
Filing Date
2024-04-16
Accepted
2024-04-16 17:29:58
Documents
90
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3025041
2 ex4-1.htm EX-4.1 55686
3 ex23-1.htm EX-23.1 4077
4 ex31-1.htm EX-31.1 17218
5 ex31-2.htm EX-31.2 17168
6 ex32-1.htm EX-32.1 10487
7 ex32-2.htm EX-32.2 8664
8 ex97-1.htm EX-97.1 36650
9 form10k_001.jpg GRAPHIC 828
  Complete submission text file 0001493152-24-014889.txt   11467119

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE cdt-20231231.xsd EX-101.SCH 74197
11 XBRL CALCULATION FILE cdt-20231231_cal.xml EX-101.CAL 75592
12 XBRL DEFINITION FILE cdt-20231231_def.xml EX-101.DEF 319417
13 XBRL LABEL FILE cdt-20231231_lab.xml EX-101.LAB 550361
14 XBRL PRESENTATION FILE cdt-20231231_pre.xml EX-101.PRE 451151
94 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1970889
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41245 | Film No.: 24848820
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)